Ventyx Biosciences
Bultinck Jennyfer has extensive experience in the biotechnology and biosciences sectors, currently serving as Senior Director of Discovery Biology and Preclinical Development at Ventyx Biosciences since March 2020, following a tenure as Director of Preclinical Discovery at Zomagen Biosciences Belgium BV. Prior to this, Bultinck held several key positions at Oxyrane, including Director of Pre-Clinical Operations and Associate Director of Preclinical Analytics. Bultinck's early career includes postdoctoral research at VIB-UGent, focusing on cell-based assays in oncology, as well as cancer research at EPFL-ISREC and a PhD from Ghent University concentrating on inflammatory responses. Additionally, Bultinck holds a Master's degree in Biotechnology from Ghent University.
This person is not in any teams
This person is not in any offices
Ventyx Biosciences
1 followers
Ventyx Biosciences is a biotechnology company with a diverse portfolio of best-in-class highly differentiated clinical and pre-clinical stage programs focused on high-value targets. Ventyx now includes combined assets from three separate companies: Oppilan Pharma, targeting S1P1R, Zomagen Biosciences, targeting NLRP3 and the inflammasome, and Ventyx Biosciences, targeting TYK2.